Ketamine Analgesic NMDA — FRCA Primary MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Non-competitive antagonism of NMDA glutamate receptors
The best answer is “Non-competitive antagonism of NMDA glutamate receptors”. Ketamine’s analgesic effect is primarily associated with NMDA-receptor antagonism, which reduces excitatory glutamatergic transmission and central sensitisation. It has additional actions, but it is not principally an alpha-2 agonist, sodium-channel blocker, GABA-A enhancer or mu-opioid agonist.
Reference: Ketamine 50 mg/mL injection, Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/100814/smpc